Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma

Lakshmaiah K. C.; Asati Vikas; Babu Govind K.; Lokanath D.; Jacob Linu Abraham; Babu Suresh M. C.; Lokesh K. N.; Rajeev L. K.; Rudresh A. H.; Saldanha Smitha; Koppaka Deepak; Patidar Rajesh; Premalata C. S.

首页> 外文期刊>European Journal of Haematology >Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma

【24h】

Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma

机译：在弥漫性大B细胞淋巴瘤患者中术前化疗之前的术前化疗的作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDuring the treatment of diffuse large B-cell lymphoma (DLBCL) patients, treatment-related toxicities are higher in the initial phase of treatment (First cycle effect). Toxicities can be tumor lysis syndrome, deterioration in performance status, febrile neutropenia, and rarely mortality. Prephase treatment before definitive chemotherapy is used in European countries to alleviate these toxicities.

机译：背景技术在治疗的初始阶段（第一循环效果）中，弥漫性大B细胞淋巴瘤（DLBCL）患者的治疗，治疗相关毒性较高。毒性可以是肿瘤裂解综合征，性能状况恶化，发热性中性蛋白，很少死亡率。在欧洲国家使用明确化疗之前的静脉检查治疗，以缓解这些毒性。

著录项

来源
《European Journal of Haematology》 |2018年第6期|共5页
作者
Lakshmaiah K. C.; Asati Vikas; Babu Govind K.; Lokanath D.; Jacob Linu Abraham; Babu Suresh M. C.; Lokesh K. N.; Rajeev L. K.; Rudresh A. H.; Saldanha Smitha; Koppaka Deepak; Patidar Rajesh; Premalata C. S.;
展开▼
作者单位

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Med Oncol Bengaluru India;

Kidwai Canc Inst Dept Pathol Bengaluru India;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词
diffuse large B-cell lymphoma; first cycle effect; lymphoma; prephase; prephase treatment DLBCL;

机译：弥漫性大B细胞淋巴瘤;第一循环效果;淋巴瘤;静脉粥样族治疗DLBCL;

相似文献

外文文献
中文文献
专利

1. Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma [J] . Lakshmaiah K. C., Asati Vikas, Babu Govind K., European Journal of Haematology . 2018,第6期

机译：在弥漫性大B细胞淋巴瘤患者中术前化疗之前的术前化疗的作用
2. A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomas [J] . Malpica Luis, Mufuka Bolanle, Galeotti Jonathan, Leukemia and lymphoma . 2020,第5a6期

机译：在激进淋巴瘤中明确的多层化疗之前对静脉检查治疗的回顾性研究
3. A Retrospective Study on Prephase Therapy Prior to Definitive Multiagent Chemotherapy in Aggressive Lymphomas [J] . Castillo Luis E. Malpica, Galeotti Jonathan, Grover Natalie S., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：在激进淋巴瘤中明确的多层化疗之前对静脉检查治疗的回顾性研究
4. Survival Prediction in Patients with Diffuse Large B-cell Lymphoma Using Logistic and Neural Network Models [C] . Chin-Chuan Chang, Chien-Hua Chen, Jer-Guang Hsieh, IEEE Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability . 2021

机译：逻辑和神经网络模型弥漫性大B细胞淋巴瘤患者的存活预测
5. Effectiveness of Novel Immunotherapy and Chemotherapy Treatments for Follicular and Diffuse Large B-Cell Lymphomas [D] . Butsenko, Dmitriy. 2017

机译：新型免疫疗法和化学疗法对滤泡性和弥漫性大B细胞淋巴瘤的疗效
6. Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective multicentre non-interventional study [O] . Jianqiu Wu, Yongping Song, Liping Su, 2016

机译：利妥昔单抗联合化学疗法作为中国弥漫性大B细胞淋巴瘤患者常规治疗的一线治疗：一项前瞻性多中心非干预性研究
7. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-Cell Non-Hodgkin’s lymphoma1,2 1Expert panel members and authors of the review are: Theresa Hahn, PhD, Roswell Park Cancer Institute, Buffalo, NY; Steven N. Wolff, MD, Vanderbilt University, Nashville, TN, Myron Czuczman, MD, Roswell Park Cancer Institute, Buffalo, NY; Richard I. Fisher, MD, Cardinal Bernardin Cancer Center, Loyola University, Chicago, IL; Hillard M. Lazarus, MD, Comprehensive Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH; Philip L. McCarthy, MD, Roswell Park Cancer Institute, Buffalo, NY; Julie Vose, MD, University of Nebraska Medical Center, Omaha, NE; Lisa Warren, Cure for Lymphoma Foundation, New York, NY; and Richard Watt, MD, United Resource Networks, Minneapolis, MN. 2Reference: Hahn T, Wolff SN, Czuczman M, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence-based review. Biol Blood Marrow Transplant. 2001;7:308–331. [O] . 2003

机译：造血干细胞移植的细胞毒性治疗在治疗弥漫性大细胞B细胞非霍奇金淋巴瘤1,2中的作用1，专家小组成员和评价的作者是：纽约州布法罗罗斯威尔公园癌症研究所的特蕾莎·哈恩博士；田纳西州纳什维尔范德比尔特大学医学博士斯蒂芬·沃尔夫（Steven N. Wolff），纽约州布法罗罗斯维尔公园癌症研究所医学博士迈伦·库兹曼（Myron Czuczman）；理查德·费舍尔（Richard I. Fisher）医学博士，伊利诺伊州芝加哥洛约拉大学贝纳尔丁枢机主教癌症中心；俄亥俄州克利夫兰凯斯西储大学克利夫兰大学医院综合癌症中心医学博士Hillard M. Lazarus；纽约州布法罗罗斯韦尔公园癌症研究所医学博士Philip L.内布拉斯加州奥马哈市内布拉斯加大学医学中心医学博士Julie Vose；丽莎·沃伦（Lisa Warren），纽约州纽约市淋巴瘤基金会的治疗；和明尼苏达州明尼阿波利斯市联合资源网络公司的医学博士Richard Watt。 2参考文献：Hahn T，Wolff SN，Czuczman M等。一项基于证据的综述：造血干细胞移植的细胞毒性治疗在弥漫性大细胞B细胞非霍奇金淋巴瘤治疗中的作用。 Biol骨髓移植。 2001; 7：308-331。

Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma

摘要

著录项

相似文献

相关主题

期刊订阅